Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

NCT05602727 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

99

Enrollment

INDUSTRY

Sponsor class

Stopped Voluntarily terminated due to benefit/risk assessment

Conditions

Alzheimer's Disease

Interventions

DRUG: MK-1942
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC